SIRL-1 deficiency reveals pro-inflammatory IL-8 axis in inflammatory bowel disease: a novel diagnostic ratio

SIRL-1 缺陷揭示炎症性肠病中的促炎性 IL-8 轴:一种新的诊断比率

阅读:1

Abstract

BACKGROUND: Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn's Disease, is characterized by chronic intestinal inflammation, neutrophil infiltration and elevated pro-inflammatory cytokines like Interleukin-8 (IL-8). While pro-inflammatory mechanisms are well-studied, the contribution of intrinsic inhibitory immune checkpoints to IBD pathogenesis is less understood. This study aimed to assess the expression and function of Signal Inhibitory Receptor on Leukocytes-1 (SIRL-1) in IBD and to evaluate the diagnostic utility of the SIRL-1/IL-8 ratio. METHODS: Peripheral venous blood was collected from 90 participants (IBD patients and healthy volunteers). Neutrophil SIRL-1 protein expression was quantified by flow cytometry, while VSTM1 (SIRL-1 gene) and IL-8 messenger RNA levels were measured by RT-qPCR. Serum IL-8 concentrations were determined using a flow cytometry microbead array. Statistical analyses included Mann-Whitney U tests, Kruskal-Wallis tests, Spearman correlations, and Receiver Operating Characteristic (ROC) curve analysis. RESULTS: IBD patients exhibited significant downregulation of SIRL-1 protein and VSTM1 messenger RNA in peripheral blood neutrophils. This downregulation was constitutive in Crohn's Disease, irrespective of disease activity. Conversely, serum IL-8 levels were significantly elevated in IBD cohort, driven primarily by the active Ulcerative Colitis subgroup, whereas Crohn's Disease patients did not show significant elevation. A significant inverse correlation was observed between neutrophil SIRL-1 expression and serum IL-8 (r = -0.5789, p = 0.0118). Crucially, the SIRL-1/IL-8 ratio demonstrated superior diagnostic accuracy for distinguishing IBD from healthy controls (AUC = 0.82), outperforming individual markers, and was notably effective in Crohn's Disease (AUC = 0.86). CONCLUSIONS: Deficiency in SIRL-1 appears to be a permissive factor for the pro-inflammatory IL-8 axis in IBD. The SIRL-1/IL-8 ratio represents a promising novel diagnostic biomarker that presents enhanced precision by reflecting the imbalance between immune regulation and inflammation. Notably, this ratio revealed superior diagnostic value in Crohn's Disease despite the lack of significant IL-8 elevation, highlighting its utility in capturing intrinsic immune defects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。